New study aims to find safe scabies treatment for toddlers
NCT ID NCT05500326
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well a single dose of ivermectin works in children under 5 with scabies. Researchers want to make sure the dose is safe and effective for this age group. About 120 children in Laos will take part, and the study will measure drug levels in the blood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCABIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Banchieng Health Centre
Kasy District, Vientiane Province, Laos
-
Hinngoon Health Centre
Kasy District, Vientiane Province, Laos
-
Kasy District Hospital
Kasy District, Vientiane Province, Laos
-
Poonglack Health Centre
Kasy District, Vientiane, Laos
-
ThongMeud Health Centre
Kasy District, Vientiane, Laos
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single pill cure scabies? new study tests three doses
- AI app aims to help frontline workers diagnose neglected skin diseases
- Could a common parasite drug help young kids with scabies?
- New ivermectin minitablets could treat scabies in infants and toddlers
- New study aims to find best scabies treatment for babies
- Scabies cure rates under the microscope: national study reveals treatment success